GLP-1 Market
LLY $1152.70 ▲ +0.0% NVO $43.24 ▲ +0.1% PFE $27.61 ▼ -0.1% VKTX $28.99 ▼ -1.3% KLRA $12.83 ▼ -0.7% GPCR $35.00 ▼ -0.3% RHHBY $54.04 ▼ -1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

palcebo

Company
MindRank AI Ltd
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
2 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

2 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 19, 2026

Find a Clinical Trial Near Me

See recruiting studies for palcebo and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT06706791

    Effect of Empagliflozin on Quality of Life in Chronic Heart Failure Patients With Diabetes Mellitus Type II

    Not yet reported Fazaia Ruth Pfau Medical College 156 participants Est. completion 2026-12-01 1 site Stand-alone
    Heart failure
    View official trial listing →
  • Recruiting NCT NCT06716151

    A Study to Evaluate HB0034 in Healthy Chinese Adult Participants

    Not yet reported Shanghai Huaota Biopharmaceutical Co., Ltd. 60 participants Est. completion 2025-11-20 1 site
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT00626548

    A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer

    Not yet reported AstraZeneca 2577 participants Est. completion 2011-05 322 sites
    Other conditions: Prostate Cancer
    View official trial listing →
  • Completed NCT NCT01048333

    Evaluate Onset of Effect in Patients With Chronic Obstructive Pulmonary Disease (COPD) Treated With Formoterol Turbuhaler®

    Not yet reported AstraZeneca 109 participants Est. completion 2010-05 17 sites Stand-alone
    Other conditions: Chronic Obstructive Pulmonary Disease
    View official trial listing →
  • Status unknown NCT NCT01267331

    Cell Therapy in Patients With Chronic Ischemic Heart Disease Undergoing Cardiac Surgery

    Not yet reported, Not yet reported Chinese PLA General Hospital 60 participants Est. completion 2013-06 1 site
    Cardiovascular disease Other conditions: Chronic Myocardial Ischemia, Left Ventricular Dysfunction
    View official trial listing →
  • Withdrawn NCT NCT01386255

    Placebo Controlled Study of Baclofen for GERD in Children With Cerebral Palsy

    Not yet reported Boston Children's Hospital Est. completion 2012-04-30 1 site
    Other conditions: Cerebral Palsy, GERD
    View official trial listing →
  • Completed NCT NCT01629849

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 1021958 in Otherwise Healthy Controlled Asthmatic Subjects

    Not yet reported Boehringer Ingelheim 84 participants Est. completion 2012-12 1 site
    Other conditions: Healthy, Asthma
    View official trial listing →
  • Completed NCT NCT01638403

    Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.

    Not yet reported Bioprojet 180 participants Est. completion 2012-07 1 site
    Other conditions: Treatment of Excessive Daytime Sleepiness in Narcolepsy
    View official trial listing →
  • Completed NCT NCT01845181

    "First-in-human" Study To Assess the Safety and Tolerability of PBF-680 in Male Healthy Volunteers

    Not yet reported Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 32 participants Est. completion 2013-09 2 sites
    Other conditions: Asthma
    View official trial listing →
  • Status unknown NCT NCT01851759

    Methanesulfonic Acid Cinepazide Injection for Treatment of Acute Cerebral Infarction

    Not yet reported Xijing Hospital 288 participants Est. completion 2014-08 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT01983046

    Rectal Short Chain Fatty Acids Combinations and Substrate and Energy Metabolism

    Not yet reported Maastricht University Medical Center 12 participants Est. completion 2014-02 1 site
    Type 2 diabetes Other conditions: Obesity
    View official trial listing →
  • Completed NCT NCT02538458

    Efficacy and Safety of 3% Hypertonic Saline Inhalation (24h vs 72h) to Treat Acute Bronchiolitis in Hospitalized Infants

    Not yet reported University Hospital, Grenoble 120 participants Est. completion 2016-03 1 site
    Other conditions: Bronchiolitis
    View official trial listing →
  • Completed NCT NCT02847143

    Ocytocine and Cerebral Activation in Relation With Attachement

    Not yet reported Centre Hospitalier Universitaire de Besancon 100 participants Est. completion 2018-04-27 1 site Stand-alone
    Other conditions: Attachement Style
    View official trial listing →
  • Withdrawn NCT NCT02982642

    Efficacy and Safety of 1612 Capsules in aMnestic Mild Cognitive Impairment

    Not yet reported Dongzhimen Hospital, Beijing Est. completion 2018-12 1 site
    Other conditions: Mild Cognitive Impairment
    View official trial listing →
  • Completed NCT NCT03636204

    A First in Human Study in Healthy Volunteers and in Participants With Frontotemporal Dementia With Granulin (GRN) Mutation

    Not yet reported Alector Inc. 64 participants Est. completion 2019-12-31 8 sites
    Other conditions: Healthy, Frontotemporal Dementia
    View official trial listing →
  • Completed NCT NCT04022941

    Efficacy and Safety of Sodium Benzoate in the Management of Hyperammonemia in Infants, Children and Adolescent With Chronic Liver Disease.

    Not yet reported Institute of Liver and Biliary Sciences, India 108 participants Est. completion 2018-12-31 1 site
    Other conditions: Chronic Liver Disease
    View official trial listing →
  • Status unknown NCT NCT04142151

    Double Randomized and Placebo Controlled Trail of Sanchitongshu Combined Antiplatelet Drug to Prevent Ischemic Stroke

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 60 participants Est. completion 2020-12-31 1 site
    Cardiovascular disease Other conditions: Antiplatelet Effect
    View official trial listing →
  • Completed NCT NCT04158167

    Neurobiological Effects of Oxytocin in Schizophrenia - Imaging Study

    Not yet reported National Institute of Mental Health and Neuro Sciences, India 90 participants Est. completion 2018-12-30 1 site
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT04250363

    Chemoprophylactic Activity of M5717 in PfSPZ Challenge Model

    Not yet reported Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany 39 participants Est. completion 2021-08-18 1 site
    Other conditions: Healthy
    View official trial listing →
  • Withdrawn NCT NCT04325802

    Treatment of Chronic Itch in Atopic Dermatitis With Opioid Antagonist Naltrexone

    Not yet reported University of Minnesota Est. completion 2024-06 1 site
    Other conditions: Atopic Dermatitis, Pruritus, Pruritus Chronic, Dermatitis
    View official trial listing →
  • Completed NCT NCT04475848

    A Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of RO6953958 in Healthy Participants

    Not yet reported Hoffmann-La Roche 88 participants Est. completion 2022-02-06 1 site
    Other conditions: Autistic Disorder, Autism Spectrum Disorder, Child Development Disorders, Pervasive, Mental Disorders, Neurodevelopmental Disorders
    View official trial listing →
  • Completed NCT NCT04665648

    Clinical Efficacy and sAfety of Intravenous Infusion of Nicorandil During Primary Percutaneous Coronary Intervention

    Not yet reported Fudan University 1500 participants Est. completion 2024-12-31 1 site
    Cardiovascular disease Other conditions: Percutaneous Coronary Intervention
    View official trial listing →
  • Status unknown NCT NCT04691063

    The Study is Being Conducted to Evaluate the Efficacy and Safety of SHR-1316 in Combination With Chemo-radiotherapy in Patients With LS-SCLC.

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 486 participants Est. completion 2025-05-15 1 site
    Other conditions: Small-cell Lung Cancer
    View official trial listing →
  • Completed NCT NCT05064345

    A Study to Evaluate HB0034 in Healthy Adult Participants

    Not yet reported Shanghai Huaota Biopharmaceutical Co., Ltd. 56 participants Est. completion 2022-09-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT05069883

    Role of Oral Steroids in Reducing Recurrence of Urethral Stricture After Direct Vision Internal Urethrotomy

    Not yet reported Services Hospital, Lahore 180 participants Est. completion 2021-03-31 1 site
    Other conditions: Recurrence
    View official trial listing →
  • Status unknown NCT NCT05556083

    Sildenafil Added Effect in Dapoxetine Non-responding Mono-symptomatic Premature Ejaculation (PE)

    Not yet reported Al-Azhar University 200 participants Est. completion 2023-11-01
    Other conditions: Premature Ejaculation
    View official trial listing →
  • Withdrawn NCT NCT05611372

    Efficacy and Safety of Rasagiline in Prodromal Parkinson's Disease

    Not yet reported, Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine Est. completion 2026-12-31
    Other conditions: REM Sleep Behavior Disorder, Parkinson Disease, Synucleinopathies
    View official trial listing →
  • Completed NCT NCT06187727

    Henagliflozin Reducing Infarct Size After Priamry PCI in Patients With ST Segment Elevation Myocardial Infarction

    Not yet reported Qian geng 248 participants Est. completion 2025-10-01 1 site
    Cardiovascular diseaseHeart failure
    View official trial listing →
  • Not yet recruiting NCT NCT06624384

    Efficacy and Safety of Topical Cyclosporine 0.05% and Lifitgrast on the Ocular Surface Symptom After Photorefractive Keratectomy in Feiz Hospital, Isfahan, 2024

    Not yet reported Mohsen Pourazizi 150 participants Est. completion 2024-12-30 1 site
    Other conditions: Ocular Surface Symptom, Ocular Surface Disease, Eye Pain, Eye Inflammation
    View official trial listing →
  • Not yet recruiting NCT NCT06723002

    Effect of Olive Leaf Extracts on Endothelial Dysfunction in Patients With Acute Coronary Syndrome

    Not yet reported, Not yet reported University of Monastir 300 participants Est. completion 2025-12-30
    Other conditions: Acute Coronary Syndrome (ACS), Reactive Hyperemia, Endothelial Dysfunction
    View official trial listing →
  • Completed NCT NCT06778850

    A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight Participants

    Not yet reported, Not yet reported MindRank AI Ltd 128 participants Est. completion 2024-09-30 1 site Stand-alone
    Other conditions: Overweight and Obese Volunteers
    View official trial listing →
  • Not yet recruiting NCT NCT06848907

    Clinical Study on the Treatment of MAFLD With Ganzhixiao Capsules

    Not yet reported Dong Hui 138 participants Est. completion 2028-05-30
    Other conditions: MAFLD
    View official trial listing →
  • Completed NCT NCT06901648

    A Study of HS-20094 in Patients With T2DM

    Not yet reported Jiangsu Hansoh Pharmaceutical Co., Ltd. 275 participants Est. completion 2025-04-09 1 site
    Type 2 diabetes
    View official trial listing →
  • Completed NCT NCT07124819

    Dimolegin® (60 mg) Given Once Daily in Patients Undergoing Total Hip or Knee Replacement Compared to Enoxaparin

    Not yet reported Avexima Diol LLC 215 participants Est. completion 2025-01-14 8 sites Stand-alone
    Other conditions: Arthroplasty, Replacement, Hip, Arthroplasty, Replacement, Knee, Venous Thromboembolism (VTE), Prevention
    View official trial listing →
  • Not yet recruiting NCT NCT07273799

    Comparison of Outcomes Between Topical Minoxidil Versus Oral Minoxidil for the Treatment of Androgenetic Alopecia

    Not yet reported Sheikh Zayed Federal Postgraduate Medical Institute 200 participants Est. completion 2026-06-01
    Other conditions: Androgenic Alopecia
    View official trial listing →
  • Not yet recruiting NCT NCT07354880

    Effect of Tirzepatide on Cardiovascular and Metabolic Parameters in Obese Adult Patients With Congenital Heart Disease

    Not yet reported University Medical Centre Ljubljana 30 participants Est. completion 2027-12-31
    Other conditions: Obesity & Overweight, Adult Congenital Heart Disease
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.